RecruitingNot ApplicableNCT06791226

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/ CT in Patients With Orbital Neoplasms and Compared With 18F-FDG PET/ CT

Sponsor

Peking University Third Hospital

Enrollment

50 participants

Start Date

Jul 16, 2024

Study Type

INTERVENTIONAL

Conditions

Orbital Neoplasms

Summary

To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in orbital neoplasms, and compared with 18F-FDG PET/CT.

Eligibility

Min Age: 3 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 18F-AlF-FAPI PET/CT, 18F-FDG PET/CT for people with orbital neoplasms. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TEST18F-AlF-FAPI PET/CT, 18F-FDG PET/CT

Subjects with orbital neoplasms underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT for diagnosis and staging.

Locations(1)

Dept. of Nuclear Medicine, Peking University Third Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06791226